News
MLAB
100.26
+2.15%
2.11
Mesa Labs SVP Operations Brian David Archbold disposes of 2,516 common shares for $225,197.03
PUBT · 2d ago
Weekly Report: what happened at MLAB last week (0615-0619)?
Weekly Report · 4d ago
Mesa Laboratories Executives Quietly Unload Significant Stock Holdings
TipRanks · 06/18 02:07
Mesa Labs SVP Operations Brian David Archbold disposes of 1,151 common shares worth $116,559.32
PUBT · 06/17 16:23
Mesa Laboratories names Lyndsey Crennen chief accounting officer in initial beneficial ownership filing
PUBT · 06/16 20:48
Mesa Laboratories Promotes Lyndsey Crennen to Chief Accounting Officer
TipRanks · 06/15 23:08
Mesa Labs names Lyndsey Crennen chief accounting officer
PUBT · 06/15 21:30
Weekly Report: what happened at MLAB last week (0608-0612)?
Weekly Report · 06/15 09:06
Weekly Report: what happened at MLAB last week (0601-0605)?
Weekly Report · 06/08 09:06
Mesa Laboratories Confronts Rising Cyber Resilience Compliance Risks Under EU CRA Ahead of 2026 Deadlines
TipRanks · 06/04 06:00
Mesa Laboratories returns to FY26 profit of $6.71 million; revenue rises 3.4% to $249.13 million
PUBT · 06/03 10:03
These 10 small-cap U.S. healthcare companies carry the market's most expensive valuations
Seeking Alpha · 06/02 14:20
Weekly Report: what happened at MLAB last week (0525-0529)?
Weekly Report · 06/01 09:06
Analysts Offer Insights on Technology Companies: Mesa Laboratories (MLAB), Micron (MU) and Snowflake (SNOW)
TipRanks · 05/28 10:50
Mesa Laboratories (MLAB) Profit Turnaround Tests Justification For Rich 74x P/E Multiple
Simply Wall St · 05/28 04:30
Why Mesa Laboratories Stock Is Getting Hit With a Huge Sell-Off Today
The Motley Fool · 05/27 19:56
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 05/27 17:05
Mesa Labs reports Q1 adjusted EPS $3.30 vs. $2.25 last year
TipRanks · 05/27 14:35
Mesa Laboratories' Stock Slips as 4Q Growth Misses Targets
Dow Jones · 05/27 14:33
Mesa Laboratories Inc. Q4 Loss Declines
NASDAQ · 05/27 12:33
More
Webull provides a variety of real-time MLAB stock news. You can receive the latest news about Mesa Laboratories through multiple platforms. This information may help you make smarter investment decisions.
About MLAB
Mesa Laboratories, Inc. designs and manufactures life sciences tools and critical control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. The Company's segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, sells and services automated systems for protein analysis and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications, such as renal care, environmental and process monitoring.